Health and Fitness Health and Fitness
Tue, October 12, 2010
[ Tue, Oct 12th 2010 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. ble Breaches of Fiduciary Duty by the Board of Ki
[ Tue, Oct 12th 2010 ] - Market Wire
Dr. Reddy's to Release Q2 FY11 Results on October .. Slated for October 23, 5:00 PM IST / 7.30 AM EST
[ Tue, Oct 12th 2010 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation of .. ion of King Pharmaceuticals, Inc. by Pfizer, Inc.
[ Tue, Oct 12th 2010 ] - Market Wire
Universal American Corp. Schedules Third Quarter .. ase and Conference Call for Tuesday, November 2nd
[ Tue, Oct 12th 2010 ] - Market Wire
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
[ Tue, Oct 12th 2010 ] - Market Wire
Kendall Law Group Investigates King Pharmaceuticals, Inc. Acquisition for Shareholders
[ Tue, Oct 12th 2010 ] - Market Wire
RehabCare To Announce Third Quarter 2010 Results
[ Tue, Oct 12th 2010 ] - Market Wire
Imaging Dynamics Company Ltd. - Announces Early Warning Report
[ Tue, Oct 12th 2010 ] - Market Wire
Vertex Pharmaceuticals Announces the Date of its .. 010 Financial Results Conference Call and Webcast
[ Tue, Oct 12th 2010 ] - Market Wire
New Hope Center for Reproductive Medicine To Offer IntegraMed® Attain® IVF Programs
[ Tue, Oct 12th 2010 ] - Market Wire
R. Scott Tobin Renuncia a Todos sus Cargos en Health Discovery Corporation
[ Tue, Oct 12th 2010 ] - Market Wire
Richard Scott Tobin tritt von allen seinen Positionen bei der Health Discovery Corporation zurck
[ Tue, Oct 12th 2010 ] - Market Wire
Pluristem Therapeutics Raises Approximately $5 Million in Private Placement of Common Stock
[ Tue, Oct 12th 2010 ] - Market Wire
Covidien komt met nieuwe bewijzen voor de klinisc .. voor het herstel van abdominale ingewandsbreuken
[ Tue, Oct 12th 2010 ] - Market Wire
Covidien legt neue Daten vor, die den klinischen .. r die Hernien- und Bauchwandreparatur hervorheben
[ Tue, Oct 12th 2010 ] - Market Wire
Columbia Laboratories Announces USPTO Notice of A .. lowance for Key Progesterone Preterm Birth Patent
[ Tue, Oct 12th 2010 ] - Market Wire
Covidien comunica nuove prove a sostegno del valo .. riparazione della parete addominale e delle ernie
[ Tue, Oct 12th 2010 ] - Market Wire
Covidien annonce de nouvelles preuves qui mettent .. de ses produits de r©paration des hernies et de
[ Tue, Oct 12th 2010 ] - Market Wire
Illumina to Announce Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
Mon, October 11, 2010
[ Mon, Oct 11th 2010 ] - Market Wire
Covidien Announces New Evidence That Underscores .. alue of Hernia and Abdominal Wall Repair Products
[ Mon, Oct 11th 2010 ] - Market Wire
R. Scott Tobin si dimette da tutte le cariche rivestite presso Health Discovery Corporation
[ Mon, Oct 11th 2010 ] - Market Wire
Alcon Introduces New Systane® BALANCE Lubricant .. Dry Eye Patients with Meibomian Gland Dysfunction
[ Mon, Oct 11th 2010 ] - Market Wire
CORRECTING and REPLACING Health Management Associ .. Quarter 2010 Earnings Conference Call and Webcast
[ Mon, Oct 11th 2010 ] - Market Wire
Prestige Brands Holdings, Inc. to Release Fiscal 2011 Second Quarter Earnings on November 4th
[ Mon, Oct 11th 2010 ] - Market Wire
Health Management Associates, Inc. Announces Thir .. Quarter 2010 Earnings Conference Call and Webcast
[ Mon, Oct 11th 2010 ] - Market Wire
WellCare Announces Leadership Team Appointments
[ Mon, Oct 11th 2010 ] - Market Wire
Psychiatric Solutions Announces Date for Third Quarter 2010 Earnings Release
[ Mon, Oct 11th 2010 ] - Market Wire
??????????????????26????,Biogen Idec??????45???,???????????????????
[ Mon, Oct 11th 2010 ] - Market Wire
R. Scott Tobin legt zijn functies bij Health Discovery Corporation neer
[ Mon, Oct 11th 2010 ] - Market Wire
Apricus Biosciences to Present at the PrecisionIR .. tech, Healthcare and Pharma Virtual Conference on

Apricus Biosciences to Present at the PrecisionIR Informed Investors Forum Biotech, Healthcare and Pharma Virtual Conference on


Published on 2010-10-11 07:51:09 - Market Wire
  Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--Apricus Biosciences (aApricus Bioa) (Nasdaq: APRI), backed by a revenue generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, today announced that Bassam Damaj, Ph.D., President and Chief Executive Officer, will present at PrecisionIR's Informed Investors Forum Biotech, Healthcare and Pharma Virtual Conference on October 13, 2010 at 12:00pm Eastern time. Interested parties can access the audio webcast with slide presentation at [ http://www.vcall.com/customevent/conferences/biotech/20101013/index.html ].

About Apricus Biosciences

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enable multi-route administration of new and improved compounds across numerous therapeutic classes. Future growth is expected to be driven primarily through out-licensing of this technology for the development and commercialization of such compounds to pharmaceutical and biotechnology companies, worldwide. Concurrently, the Company is seeking to monetize its existing product pipeline, including compounds from pre-clinical through Phase 3, currently focused on dermatology, sexual dysfunction and cancer. For further information on Apricus Bio and its subsidiaries, visit [ http://www.apricusbio.com ].

Contributing Sources